Immunology biotech Acelyrin has determined that its CRO partner Fortrea is resp...
Bayer’s stock price has plummeted to its lowest since 2005 after a clinical tri...
Building on the increased adoption of digital trial capabilities due to the Cov...
Emergent BioSolutions has secured a $75m contract for the acquisition of the FD...
About 20 million disabled people may be erased if the U.S. Census Bureau moves f...
New research supports potential link between low-level lead exposure and liver i...
With biotech in a slump, the industry’s job market is feeling crimped.
The inflammation-targeting therapy Dupixent improved symptoms for patients with ...
A cell nucleus is a busy place. Cellular proteins twist and pull DNA, folding th...
The FDA on Monday approved the first treatment for people with desmoid tumors, a...
Just 3% of more than 3,700 studies run exclusively in Canada over a recent 10-ye...
Bioscience job postings have dropped from around 19,000 in February 2022 to 10,0...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Amid concerns over the use of medically important antibiotics given to food-prod...
Recent advances in generative artificial intelligence have spurred developments ...
What if a single one-dollar dose could cure cancer? Credit: Texas A&M Engineerin...
